The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01700244
Verified June 2013 by Nanostim, Inc.. Recruitment status was: Active, not recruiting
An evaluation of a safety and performance of a new cardiac pacemaker
Condition or disease
Atrial Fibrillation With 2 or 3° AV or Bifascicular Bundle Branch (BBB) BlockNormal Sinus Rhythm With 2 or 3° AV or BBB BlockSinus Bradycardia With Infrequent Pauses or Unexplained Syncope With EP Findings
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Subject must have one of the following clinical indications:
Chronic atrial fibrillation with 2 or 3° AV or bifascicular bundle branch block (BBB block) ; or
Normal sinus rhythm with 2 or 3° AV or BBB block and a low level of physical activity or short expected lifespan (but at least one year); or
Sinus bradycardia with infrequent pauses or unexplained syncope with EP findings; and
Subject ≥18 years of age;
Subject has life expectancy of at least one year;
Subject is not enrolled in another clinical investigation;
Subject is willing to comply with clinical investigation procedures and agrees to return for all required follow-up visits, tests, and exams;
Subject has been informed of the nature of the study, agrees to its provisions and has provided written informed consent, approved by the EC;
If female, for 3 months post-operative, subject will actively practice a contraception method, or will practice abstinence, or is surgically sterilized, or is postmenopausal.
Known pacemaker syndrome, have retrograde VA conduction or suffer a drop in arterial blood pressure with the onset of ventricular pacing;
Hypersensitivity to < 1 mg of dexamethasone sodium phosphate;
Mechanical tricuspid valve prosthesis;
Pre-existing pulmonary arterial (PA) hypertension or significant physiologically-impairing lung disease;
Pre-existing pacing or defibrillation leads;
Current implantation of an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT);